1. Background
2. Objectives
3. Methods
3.1. Study Design
3.2. Sampling
3.3. Data Collection and Instruments
3.4. Intervention
| No. | Content | Assignments |
|---|---|---|
| 1 | The initial session introduces members, sets expectations, outlines group rules, ensures regular meetings, performs weekly tasks and presents them in subsequent sessions. | Members are asked to list their three most important health wishes, focusing on how they differ, how they share similar needs, and how they meet them. |
| 2 | The session's assignments were reviewed, and explanations were given on selecting ineffective behaviors like non-compliance with treatment regimens, and the reasons and methods behind such tendencies. | The assignment of this session aims to determine the level of health members desire and their current level of health, based on a continuum from 1 to 100. |
| 3 | Review the assignments of the previous session. Explanation about general behavior and its four components (thought, action, physiology, and feeling), machine learning of behavior in humans, and explanation of aggression as a general behavior | Members should explain the components of non-compliant behaviors. |
| 4 | The session focuses on understanding behavior, self-control, and positive aspects while teaching members about behavior, feelings, and internal and external control. It also emphasizes non-compliance as an internal choice. | The tasks of this session focus on the control of human behavior, examining both external and internal factors, and the actions taken to achieve desired outcomes. |
| 5 | The fifth session emphasized the importance of contrasting qualitative and real-world behavior, emphasizing responsibility, familiarizing members with responsibilities, and promoting responsible behavior choices. | Participants were asked if their goals would lead them to their desired destination and if they had a roadmap to guide them. |
| 6 | The session provided feedback, reviewed assignments, and taught seven destructive and seven effective behaviors to achieve goals, emphasizing the importance of avoiding excuses. | Past failures and excuses highlight unrealistic behaviors and the need for alternative ways to achieve desired outcomes. |
| 7 | Review the assignments of the last session. Determining the ways to achieve the demands from the members' language. Explanation of effective and ineffective solutions considering the two characteristics of being realistic and responsible | Checking whether the specified ways have been effective? |
| 8 | Explanation regarding the components of the therapeutic diet (exercise, medicine, nutrition) and the effect of each one on diabetes control | Members can briefly explain the effects of each component in diabetes control for the next meetings. |
| 9 | The session discussed the importance of a SMART plan to achieve goals, identify member solutions, and introduce program features. | Writing the program in writing with the SMART feature of the program |
| 10 | The tenth session emphasized the importance of commitment, requiring written commitment from members, and personal goals, emphasizing responsibility and goal achievement. |
3.5. Data Analysis
4. Results
| Variables | Intervention (n = 27) | Control (n = 27) | Total (N = 54) | Test Statistic | P-Value |
|---|---|---|---|---|---|
| Age | 51.96 ± 10.56 | 55.30 ± 7.9 | 53.63 ± 9.41 | -1.31 | 0.196 |
| BMI | 27.17 ± 5.63 | 29.16 ± 5.16 | 28.12 ± 5.45 | -1.35 | 0.182 |
| Gender | 1.94 | 0.264 | |||
| Female | 14 (51.9) | 19 (70.4) | 21 (38.9) | ||
| Male | 13 (48.1) | 8 (29.6) | 33 (68.1) | ||
| Marital status | 0.750 | 0.386 | |||
| Single | 4 (14.8) | 2 (7.4) | 6 (11.1) | ||
| Married | 23 (85.2) | 25 (92.8) | 48 (88.9) | ||
| Education | 2.03 | 0.362 | |||
| Primary school | 6 (22.2) | 10 (37.0) | 16 (29.6) | ||
| Middle and high school | 15 (55.6) | 14 (51.9) | 29 (53.7) | ||
| University education | 6 (22.2) | 3 (11.1) | 9 (16.7) | ||
| Source of information | 1.24 | 0.538 | |||
| Treatment staff | 17 (85.5) | 20 (87.0) | 37 (86.0) | ||
| Self-learning | 3 (15.0) | 2 (8.7) | 5 (11.6) | ||
| Media | 0 (0.0) | 1 (4.3) | 1 (2.3) | ||
| Income | 3.97 | 0.137 | |||
| Desirable | 3 (11.1) | 2 (7.4) | 5 (9.3) | ||
| Relatively desirable | 18 (66.7) | 12 (44.4) | 30 (55.6) | ||
| Undesirable | 6 (22.2) | 13 (48.1) | 19 (35.2) | ||
| Smoking | 1.41 | 0.493 | |||
| Yes | 3 (11.1) | 1 (33.7) | 4 (7.4) | ||
| No | 24 (88.9) | 26 (96.3) | 50 (92.6) | ||
| Duration of Diabetes | 0.18 | 0.915 | |||
| Less than 5 | 9 (33.3) | 9 (33.3) | 18 (33.3) | ||
| 5 - 10 | 3 (11.1) | 4 (14.8) | 7 (13.0) | ||
| More than 10 | 15 (55.6) | 14 (51.9) | 29 (53.7) | ||
| Family history of Diabetes | 1.54 | 0.352 | |||
| Yes | 18 (66.7) | 22 (81.5) | 40 (74.1) | ||
| No | 9 (33.3) | 5 (18.5) | 14 (25.9) |
| Variables | Intervention (n = 27) | Control (n = 27) | Test Statistic | P-Value | Total (N = 54) |
|---|---|---|---|---|---|
| Compliance to treatment regimen | |||||
| Exercise activity | |||||
| Baseline | 33.59 ± 16.74 | 22.52 ± 11.34 | 2.85 | 0.006 | 28.06 ± 15.22 |
| 1.5 months later | 45.11 ± 6.62 | 6.28 ± 8.09 | 19.19 | < 0.001 | 25.79 ± 20.82 |
| 3 months later | 47.00 ± 8.45 | 4.75 ± 7.11 | 19.83 | < 0.001 | 25.92 ± 22.63 |
| Diet | |||||
| Baseline | 68.52 ± 10.34 | 58.15 ± 4.79 | 4.73 | < 0.001 | 63.33 ± 9.54 |
| 1.5 months later | 71.78 ± 4.85 | 41.41 ± 4.02 | 25.03 | < 0.001 | 56.59 ± 15.95 |
| 3 months later | 73.78 ± 6.60 | 40.85 ± 4.69 | 21.13 | < 0.001 | 57.31 ± 17.56 |
| Stress | |||||
| Baseline | 3.07 ± 1.54 | 3.81 ± 1.92 | -1.54 | 0.130 | 3.43 ± 1.76 |
| 1.5 months later | 5.70 ± 3.49 | 6.26 ± 2.84 | -0.64 | 0.524 | 5.98 ± 3.16 |
| 3 months later | 5.48 ± 3.63 | 4.78 ± 2.31 | 0.85 | 0.339 | 5.13 ±3.03 |
| Medication instructions | |||||
| Baseline | 31.43 ± 1354 | 28.26±9.97 | 0.98 | 0.331 | 29.84 ± 11.88 |
| 1.5 months later | 23.00 ± 7.57 | 18.85±6.61 | 2.14 | 0.037 | 20.92 ± 7.35 |
| 3 months later | 19.59 ± 8.11 | 12.22 ± 3.63 | 4.31 | < 0.001 | 15.91 ± 7.25 |
| Total score | |||||
| Baseline | 119.05 ± 26.92 | 124.67 ± 15.64 | -0.94 | 0.353 | 121.86 ± 21.98 |
| 1.5 months later | 113.70 ± 10.96 | 84.96 ± 14.66 | 8.16 | < 0.001 | 99.33 ± 19.36 |
| 3 months later | 112.78 ± 13.64 | 76.78 ± 12.64 | 10.06 | < 0.001 | 94.78 ± 22.35 |
| Health Indicators | |||||
| FBS | |||||
| Baseline | 229.63 ± 118.11 | 193.19 ± 77.58 | 1.34 | 0.186 | 211.41 ± 100.6 |
| 1.5 months later | 123.59 ± 42.04 | 203.7 ± 76.14 | -4.79 | < 0.001 | 163.65 ± 73.11 |
| 3 months later | 123.22 ± 44.20 | 238.26 ± 92.49 | -5.83 | < 0.001 | 180.74±92.33 |
| Triglyceride | |||||
| Baseline | 207.81 ± 74.38 | 175.33 ± 78.47 | 1.56 | 0.125 | 191.57 ± 77.48 |
| 1.5 months later | 162.59 ± 51.58 | 199.0 ± 117.1 | -1.48 | 0.145 | 180.8 ± 91.49 |
| 3 months later | 154.96 ± 50.44 | 244.15 ± 152.6 | -2.88 | 0.006 | 199.56 ± 121.3 |
| Cholesterol | |||||
| Baseline | 176.52 ± 51.54 | 161.04 ± 38.44 | 1.25 | 0.216 | 168.78 ± 45.71 |
| 1.5 months later | 162.56 ± 46.29 | 167.44 ± 38.01 | -0.42 | 0.674 | 165.0 ± 42.06 |
| 3 months later | 146.22 ± 34.69 | 189.70 ± 43.62 | -4.05 | < 0.001 | 167.96 ± 44.78 |
| HBA1C | |||||
| Baseline | 8.15 ± 2.07 | 8.12 ± 1.90 | 0.22 | 0.827 | 8.13 ± 1.97 |
| 3 months later | 6.19 ± 1.87 | 9.03 ± 1.85 | -5.77 | < 0.001 | 7.56 ± 2.33 |
a Values are presented as mean ± SD.
| Variables | Mean Square | F | P-Value | ƞ2 |
|---|---|---|---|---|
| Compliance to Treatment Regimen | ||||
| Exercise activity | ||||
| Overall | ||||
| Time | 86.91 | 1.37 | 0.258 | 0.026 |
| Time*group | 3908.89 | 61.69 | < 0.001 | 0.543 |
| Group | 37965.43 | 196.47 | < 0.001 | 0.791 |
| Control | ||||
| Time | 2573.79 | 44.81 | < 0.001 | 0.633 |
| Intervention | ||||
| Time | 1422.01 | 20.53 | < 0.001 | 0.441 |
| Diet | ||||
| Overall | ||||
| Time | 739.64 | 25.72 | < 0.001 | 0.331 |
| Time*group | 2059.39 | 71.62 | < 0.001 | 0.579 |
| Group | 24420.50 | 9415.86 | < 0.001 | 0.887 |
| Control | ||||
| Time | 2608.75 | 160.76 | < 0.001 | 0.861 |
| Intervention | ||||
| Time | 190.27 | 4.61 | < 0.001 | 0.151 |
| Stress | ||||
| Overall | ||||
| Time | 82.78 | 15.74 | < 0.001 | 0.236 |
| Time*group | 6.57 | 1.25 | 0.291 | 0.024 |
| Group | 3700.70 | 0.07 | 0.790 | 0.001 |
| Medication instructions | ||||
| Overall | ||||
| Time | 2691.16 | 53.26 | < 0.001 | 0.506 |
| Time*group | 65.15 | 1.29 | 0.280 | 0.024 |
| Group | 971.23 | 7.45 | 0.009 | 0.125 |
| Total score | ||||
| Overall | ||||
| Time | 11353.04 | 57.91 | < 0.001 | 0.527 |
| Time*group | 6671.67 | 34.03 | < 0.001 | 0.396 |
| Group | 15730.06 | 36.34 | < 0.001 | 0.411 |
| Control | ||||
| Time | 17715.27 | 119.14 | < 0.001 | 0.047 |
| Intervention | ||||
| Time | 309.44 | 1.27 | 0.289 | 0.821 |
| Health Indicators | ||||
| FBS | ||||
| Overall | ||||
| Time | 31621.93 | 21.49 | < 0.001 | 0.292 |
| Time*group | 84941.23 | 57.71 | < 0.001 | 0.526 |
| Group | 113340.89 | 7.05 | 0.010 | 0.119 |
| Control | ||||
| Time | 15013.79 | 32.239 | < 0.001 | 0.554 |
| Intervention | ||||
| Time | 101549.37 | 40.98 | < 0.001 | 0.612 |
| Triglyceride | ||||
| Overall | ||||
| Time | 4785.97 | 2.37 | 0.098 | 0.044 |
| Time*group | 50251.39 | 24.90 | < 0.001 | 0.324 |
| Group | 39013.56 | 1.702 | 0.198 | 0.032 |
| Control | ||||
| Time | 33002.75 | 11.02 | < 0.001 | 0.298 |
| Intervention | ||||
| Time | 22034.61 | 21.18 | < 0.001 | 0.449 |
| Cholesterol | ||||
| Overall | ||||
| Time | 213.43 | 0.621 | 0.539 | 0.012 |
| Time*group | 12107.19 | 35.24 | < 0.001 | 0.404 |
| Group | 4867.56 | 1.03 | 0.315 | 0.019 |
| Control | ||||
| Time | 6112.38 | 22.49 | 0.135 | 0.464 |
| Intervention | ||||
| Time | 6208.24 | 14.95 | < 0.001 | 0.365 |
| HBA1C | ||||
| Overall | ||||
| Time | 8.96 | 20.19 | < 0.001 | 0.280 |
| Time*group | 61.20 | 138.02 | < 0.001 | 0.726 |
| Group | 51.95 | 7.53 | 0.008 | 0.127 |
| Control | ||||
| Time | 11.67 | 82.02 | < 0.001 | 0.759 |
| Intervention | ||||
| Time | 58.49 | 78.55 | < 0.001 | 0.751 |


